Carolyn C Jackson

4PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyImmunogenetics (incl. genetic immunology)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 06, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.

Thomas Martin, Saad Z Usmani, Jesus G Berdeja

|Feb 23, 2022
Comprehensive BCMA Expression Profiling in Adult Normal Human Brain Suggests a Low Risk of On-target Neurotoxicity in BCMA-targeting Multiple Myeloma Therapy.

Mathieu Marella, Xiang Yao, Vinicius Carreira

|Dec 23, 2018
Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant.

Stéphanie Boisson-Dupuis, Noe Ramirez-Alejo, Zhi Li

|May 11, 2017
Kaposi sarcoma, oral malformations, mitral dysplasia, and scoliosis associated with 7q34-q36.3 heterozygous terminal deletion.

Carolyn C Jackson, Alain Lefèvre-Utile, Anne Guimier

Pageof 1

Frequent Collaborators

1 joint publications

Stéphanie Boisson-Dupuis

1 joint publications

Noe Ramirez-Alejo

1 joint publications

Zhi Li

1 joint publications

Etienne Patin